US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 7.760
  • -0.240-3.00%
Close Dec 30 16:00 ET
  • 7.900
  • +0.140+1.80%
Post 16:49 ET
347.56MMarket Cap-14.37P/E (TTM)

Y-mAbs Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-9.74%18.46M
9.86%22.8M
-1.58%19.93M
29.96%84.82M
-25.71%23.36M
63.15%20.45M
92.19%20.75M
93.12%20.25M
87.03%65.27M
227.64%31.45M
Operating revenue
-9.74%18.46M
9.86%22.8M
-1.58%19.93M
29.96%84.82M
-25.71%23.36M
63.15%20.45M
92.19%20.75M
93.12%20.25M
87.03%65.27M
227.64%31.45M
Cost of revenue
-15.01%2.25M
-35.17%3.01M
3.07%2.15M
50.87%11.42M
0.94%2.04M
6.87%2.65M
274.92%4.65M
13.76%2.08M
200.99%7.57M
38.26%2.02M
Gross profit
-8.96%16.21M
22.87%19.78M
-2.11%17.78M
27.21%73.4M
-27.54%21.32M
76.99%17.81M
68.48%16.1M
109.91%18.17M
78.18%57.7M
261.64%29.43M
Operating expense
-3.04%24.78M
26.79%29.57M
-3.81%24.69M
-35.04%99.08M
-19.81%24.52M
-29.16%25.56M
-52.88%23.33M
-29.38%25.67M
3.18%152.51M
-30.33%30.58M
Selling and administrative expenses
33.46%13.61M
52.90%17.23M
-6.74%11.43M
-26.39%44.86M
3.17%11.14M
-25.14%10.2M
-51.17%11.27M
-8.83%12.25M
11.67%60.94M
-28.70%10.79M
Research and development costs
-27.28%11.17M
2.37%12.34M
-1.13%13.27M
-40.79%54.22M
-32.34%13.39M
-31.60%15.36M
-54.37%12.06M
-41.44%13.42M
-1.79%91.57M
-31.19%19.79M
Operating profit
-10.57%-8.57M
-35.53%-9.79M
7.91%-6.91M
72.92%-25.67M
-177.45%-3.2M
70.22%-7.75M
81.92%-7.22M
72.92%-7.5M
17.86%-94.81M
96.78%-1.15M
Net non-operating interest income expense
913.76%1.92M
-41.82%640K
-60.49%439K
734.87%4.81M
4.16%2.41M
112.52%189K
192.75%1.1M
397.86%1.11M
59.13%-757K
303.52%2.31M
Non-operating interest income
913.76%1.92M
-41.82%640K
-60.49%439K
----
----
--189K
--1.1M
--1.11M
----
----
Total other finance cost
----
----
----
-734.87%-4.81M
----
----
----
----
--757K
----
Other net income (expense)
Income before tax
12.01%-6.65M
-49.42%-9.15M
-1.24%-6.47M
78.17%-20.87M
-168.54%-793K
72.54%-7.56M
85.11%-6.12M
77.23%-6.39M
-72.90%-95.57M
103.14%1.16M
Income tax
85.03%346K
-44.13%100K
160K
561K
195K
187K
179K
0
0
0
Net income
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
-72.90%-95.57M
103.14%1.16M
Net income continuous Operations
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
-72.90%-95.57M
103.14%1.16M
Minority interest income
Net income attributable to the parent company
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
-72.90%-95.57M
103.14%1.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.67%-7M
-46.76%-9.25M
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
-72.90%-95.57M
103.14%1.16M
Basic earnings per share
11.11%-0.16
-50.00%-0.21
0.00%-0.15
77.63%-0.49
-166.67%-0.02
71.43%-0.18
85.11%-0.14
76.56%-0.15
-71.09%-2.19
103.53%0.03
Diluted earnings per share
11.11%-0.16
-50.00%-0.21
0.00%-0.15
77.63%-0.49
-166.67%-0.02
71.43%-0.18
85.11%-0.14
76.56%-0.15
-71.09%-2.19
103.53%0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -9.74%18.46M9.86%22.8M-1.58%19.93M29.96%84.82M-25.71%23.36M63.15%20.45M92.19%20.75M93.12%20.25M87.03%65.27M227.64%31.45M
Operating revenue -9.74%18.46M9.86%22.8M-1.58%19.93M29.96%84.82M-25.71%23.36M63.15%20.45M92.19%20.75M93.12%20.25M87.03%65.27M227.64%31.45M
Cost of revenue -15.01%2.25M-35.17%3.01M3.07%2.15M50.87%11.42M0.94%2.04M6.87%2.65M274.92%4.65M13.76%2.08M200.99%7.57M38.26%2.02M
Gross profit -8.96%16.21M22.87%19.78M-2.11%17.78M27.21%73.4M-27.54%21.32M76.99%17.81M68.48%16.1M109.91%18.17M78.18%57.7M261.64%29.43M
Operating expense -3.04%24.78M26.79%29.57M-3.81%24.69M-35.04%99.08M-19.81%24.52M-29.16%25.56M-52.88%23.33M-29.38%25.67M3.18%152.51M-30.33%30.58M
Selling and administrative expenses 33.46%13.61M52.90%17.23M-6.74%11.43M-26.39%44.86M3.17%11.14M-25.14%10.2M-51.17%11.27M-8.83%12.25M11.67%60.94M-28.70%10.79M
Research and development costs -27.28%11.17M2.37%12.34M-1.13%13.27M-40.79%54.22M-32.34%13.39M-31.60%15.36M-54.37%12.06M-41.44%13.42M-1.79%91.57M-31.19%19.79M
Operating profit -10.57%-8.57M-35.53%-9.79M7.91%-6.91M72.92%-25.67M-177.45%-3.2M70.22%-7.75M81.92%-7.22M72.92%-7.5M17.86%-94.81M96.78%-1.15M
Net non-operating interest income expense 913.76%1.92M-41.82%640K-60.49%439K734.87%4.81M4.16%2.41M112.52%189K192.75%1.1M397.86%1.11M59.13%-757K303.52%2.31M
Non-operating interest income 913.76%1.92M-41.82%640K-60.49%439K----------189K--1.1M--1.11M--------
Total other finance cost -------------734.87%-4.81M------------------757K----
Other net income (expense)
Income before tax 12.01%-6.65M-49.42%-9.15M-1.24%-6.47M78.17%-20.87M-168.54%-793K72.54%-7.56M85.11%-6.12M77.23%-6.39M-72.90%-95.57M103.14%1.16M
Income tax 85.03%346K-44.13%100K160K561K195K187K179K000
Net income 9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M-72.90%-95.57M103.14%1.16M
Net income continuous Operations 9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M-72.90%-95.57M103.14%1.16M
Minority interest income
Net income attributable to the parent company 9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M-72.90%-95.57M103.14%1.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.67%-7M-46.76%-9.25M-3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M-72.90%-95.57M103.14%1.16M
Basic earnings per share 11.11%-0.16-50.00%-0.210.00%-0.1577.63%-0.49-166.67%-0.0271.43%-0.1885.11%-0.1476.56%-0.15-71.09%-2.19103.53%0.03
Diluted earnings per share 11.11%-0.16-50.00%-0.210.00%-0.1577.63%-0.49-166.67%-0.0271.43%-0.1885.11%-0.1476.56%-0.15-71.09%-2.19103.53%0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.